Inhibition of platelet-derived growth factor actions in the embryonic testis influences normal cord development and

Mehmet Uzumcu1, Kristen A Dirks, Michael K Skinner

  • 1Center for Reproductive Biology, School of Molecular Biosciences, Washington State University, Pullman, Washington 99164-4231, USA.

Insights

Platelet-derived growth factors (PDGFs) and their receptors are present in developing testes. Inhibiting PDGF signaling disrupts embryonic testicular cord formation, altering cord morphology.

Area of Science:

  • Developmental Biology
  • Reproductive Biology
  • Cell Signaling

Background:

  • Platelet-derived growth factors (PDGFs) are crucial paracrine factors involved in mesenchymal-epithelial interactions.
  • PDGF and its receptor (PDGFR) expression has been noted in perinatal, peripubertal, and adult rat testes.
  • The specific role of PDGF in embryonic testicular cord formation remains largely unknown.

Purpose of the Study:

  • To investigate the expression of PDGFs and PDGFRs during embryonic testicular cord formation.
  • To determine if inhibiting PDGF signaling affects normal cord development in embryonic testes.

Main Methods:

  • Utilized embryonic day 13 rat gonadal organ cultures for 3 days.
  • Treated cultures daily with vehicle or PDGFR-specific tyrosine phosphorylation inhibitors (AG1295 or AG1296).
  • Examined PDGF and PDGFR expression (mRNA and protein) across various embryonic and postnatal developmental stages.

Main Results:

  • Vehicle-treated testes exhibited normal cord formation.
  • Tyrphostin-treated testes displayed "swollen cords" with fewer, fused cords and increased diameter.
  • PDGF-A, PDGF-B, and PDGFR alpha/beta mRNAs were expressed throughout development; PDGF and PDGFR protein localized to specific testicular compartments.
  • Inhibitors did not impact apoptosis or cell growth but altered cord morphology.

Conclusions:

  • PDGFs and PDGFRs are expressed in a tissue-specific manner during embryonic testis cord formation.
  • Inhibition of PDGF signaling does not prevent cord formation but significantly alters normal cord development and morphology.
  • These findings offer insights into the molecular mechanisms governing male sex differentiation and embryonic testis development.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...